Alligator Bioscience AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	0.51	0.51	57.77	58.11	35.7	12.94
Other Revenue	0.01	0.33	-0.04	1.14	0.31	0.38
Revenue	0.52	0.84	57.72	59.25	36	13.33
Revenue Growth (YoY)	-98.98%	-98.55%	-2.58%	64.58%	170.14%	141.65%
Cost of Revenue	60.61	77.5	167.21	218.79	147.73	86.98
Gross Profit	-60.09	-76.66	-109.48	-159.54	-111.72	-73.66
Selling, General & Admin	31.1	43.29	70.43	79.38	68.84	56.85
Other Operating Expenses	2.37	-0.25	-0.12	-0.02	-0.03	-0
Operating Expenses	22.37	32.8	119.04	89.85	80.58	68
Operating Income	-82.46	-109.46	-228.52	-249.39	-192.3	-141.65
Interest Expense	-33.57	-44.27	-15.33	-0.48	-0.65	-0.23
Interest & Investment Income	0.22	0.27	1.31	1.88	-	-
Currency Exchange Gain (Loss)	0.07	0.43	-1.27	-0.6	-0.46	-0.14
Other Non Operating Income (Expenses)	71.08	96.91	9.92	0	0	-
EBT Excluding Unusual Items	-44.65	-56.11	-233.89	-248.59	-193.41	-142.03
Gain (Loss) on Sale of Assets	2.27	2.27	-	-	-	-
Other Unusual Items	0.82	2.49	-	-	-	-0.96
Pretax Income	-41.56	-51.35	-233.89	-248.59	-193.4	-141.74
Net Income	-41.56	-51.35	-233.89	-248.59	-193.4	-141.74
Net Income to Common	-41.56	-51.35	-233.89	-248.59	-193.4	-141.74
Shares Outstanding (Basic)	162	28	1	0	0	0
Shares Outstanding (Diluted)	162	28	1	0	0	0
Shares Change (YoY)	6486.65%	3648.83%	63.72%	103.32%	146.00%	25.61%
EPS (Basic)	-0.26	-1.87	-318.53	-554.27	-876.77	-1580.64
EPS (Diluted)	-0.26	-1.87	-318.53	-554.27	-880.00	-1580.64
Free Cash Flow	-138.14	-157.45	-221.78	-191.74	-173.05	-127.08
Free Cash Flow Per Share	-0.85	-5.72	-302.04	-427.53	-784.49	-1417.17
Gross Margin	-	-	-189.67%	-269.26%	-	-
Operating Margin	-15857.88%	-13045.89%	-395.90%	-420.90%	-534.16%	-1062.89%
Profit Margin	-7993.08%	-6120.38%	-405.19%	-419.55%	-537.22%	-1063.52%
Free Cash Flow Margin	-26565.00%	-18765.91%	-384.21%	-323.61%	-480.67%	-953.54%
EBITDA	-83.06	-109.21	-227.58	-248.24	-188.89	-136.7
D&A For EBITDA	-0.6	0.25	0.95	1.15	3.41	4.95
EBIT	-82.46	-109.46	-228.52	-249.39	-192.3	-141.65
Revenue as Reported	1.34	6.42	59.71	61.9	37.14	15.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.